Pathophysiology of bronchopulmonary dysplasia focusing on the IL-33 pathway
Not Applicable
Recruiting
- Conditions
- Bronchopulmonary dysplasia
- Registration Number
- JPRN-UMIN000048420
- Lead Sponsor
- Tokushima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Not provided
Exclusion Criteria
congenital multiple malformation syndrome, chromosome abnormalities, congenital airway malformations
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum IL-33 concentration at corrected 36 weeks
- Secondary Outcome Measures
Name Time Method IL-33 pathway IL-4, IL-5, IL-13, TSLP at corrected 36 weeks; IL-6, IL-8, VEGF, TNF-alpha and other cytokines in the acute phase.